Group 1: Earnings Performance - Cigna reported quarterly earnings of $6.72 per share, exceeding the Zacks Consensus Estimate of $6.42 per share, and up from $6.13 per share a year ago, representing an earnings surprise of 4.67% [1] - The company posted revenues of $60.47 billion for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 3.39%, compared to year-ago revenues of $48.62 billion [2] - Cigna has surpassed consensus EPS estimates four times over the last four quarters, indicating consistent strong performance [2] Group 2: Stock Performance and Outlook - Cigna shares have increased approximately 16.4% since the beginning of the year, outperforming the S&P 500's gain of 15.8% [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $7.80 for the coming quarter and $28.48 for the current fiscal year [7] - The Zacks Rank for Cigna is currently 2 (Buy), suggesting that the shares are expected to outperform the market in the near future [6] Group 3: Industry Context - The Medical - HMOs industry, to which Cigna belongs, is currently in the top 22% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Cigna's stock performance [5]
Cigna (CI) Q2 Earnings and Revenues Beat Estimates